• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library
    Biotech

    Pathos AI gets AZ funding as biotech plans to raise up to $400M

    ENDPTS

    FDA lifts hold on Amgen`s phase 1 obesity study

    FIERCE BIOTECH

    UK unveils £1B plan to become leading cancer research hub

    PRESS RELEASE

    Vertex discontinues AAV research for gene therapies

    FIERCE BIOTECH

    HHS unveils $500M universal vaccine development initiative

    PRESS RELEASE

    Arvinas lays off 33% of staff, axes Pfizer-partnered trials

    FIERCE BIOTECH

    Concentra swoops in to purchase struggling Kronos

    FIERCE BIOTECH

    Moderna targets more cost cuts amid uncertainty under RFK Jr.

    FIERCE PHARM

    J&J-backed HistoSonics explores sale at $2.5 billion valuation

    REUTERS

    SURPASS-3 Links Tirzepatide to Muscle Composition

    BUSINESSWIRE

    Bicycle Therapeutics Reports Q1 2025 Financial Results

    BUSINESSWIRE

    Natera to Report its First Quarter Results on May 8, 2025

    BUSINESSWIRE

    Repare Out-Licenses Discovery Platforms to DCx Biotherapeutics

    BUSINESSWIRE

    Precision BioSciences Announces Presentations at ASGCT Meeting

    BUSINESSWIRE

    QbDVision Raises $13M to Accelerate Digital CMC Transformation

    BUSINESSWIRE

    Lineage Cell Therapeutics to Report Q1 2025 Results on May 13

    BUSINESSWIRE

    Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program

    BUSINESSWIRE

    Mythic Therapeutics to Present Updated Data at 2025 ASCO Meeting

    BUSINESSWIRE

    Nutcracker Therapeutics to Showcase NMU-Symphony™ Platform

    BUSINESSWIRE

    Mammoth Shows Preclinical CRISPR Data at ASGCT 2025

    BUSINESSWIRE

    AviadoBio Completes Phase 1/2 ASPIRE-FTD Trial for FTD-GRN

    BUSINESSWIRE

    Vaccine publication shows fewer Adverse events with PharmaJet com

    BUSINESSWIRE

    Prothena to Report First Quarter 2025 Financial Results on May 8

    BUSINESSWIRE

    InnoCare`s Zurletrectinib Gets Priority Review from China`s NMPA

    BUSINESSWIRE

    Blue Earth Therapeutics starts Phase 2 Trial for Lutetium (177Lu)

    PR NEWSWIRE

    Armata Pharmaceuticals gets $4.65M from U.S. DoD for AP-SA02 trial

    PR NEWSWIRE

    Alkermes plc Reports First Quarter 2025 Financial Results

    PR NEWSWIRE

    Univar Solutions Preferred Distributor for Tedia`s Purity Solvent

    PR NEWSWIRE

    Everads to Present Five Abstracts at ARVO 2025

    PR NEWSWIRE

    S&E bio gets Korea`s first approval for exosome therapy trial

    PR NEWSWIRE

    TransCode Reports Progress on Phase 1a Trial in Metastatic Cancer

    PR NEWSWIRE

    Botox Backs Entrepreneurs via Confidence Project

    PR NEWSWIRE

    SK Life Publishes Molecular Glue Study in Nature

    PR NEWSWIRE

    Moderna Reports Q1 2025 Financial Results and Business Updates

    ACCESSWIRE

    UK`s Genus secures FDA approval for PRP gene edit

    REUTERS

    GSK `well positioned` for drug tariffs as vaccine sales slip

    FIERCE PHARMA

    Immunic MS asset misses primary goal of midstage trial

    FIERCE BIOTECH

    US FDA approves J&J`s immune disorder drug

    PRESS RELEASE

    Novartis to buy Regulus in up to $1.7 Billion deal

    REUTERS

    RoosterBio partners Thermo Fisher for Cell Therapy Advancement

    PR NEWSWIRE

    23andMe to have overseer for genetic data in bankruptcy

    REUTERS

    GSK ready for tariffs after exceeding forecasts

    REUTERS

    CHMP recommends label update for Roche`s Phesgo

    GLOBENEWSWIRE

    Immuno-Oncology Results Presented at AACR Annual Meeting 2025

    GLOBENEWSWIRE

    Nanobiotix Shares Ph1 Data on JNJ-1900 in Pancreas

    GLOBENEWSWIRE

    Notice of Annual General Meeting 2025

    GLOBENEWSWIRE

    Er-Kim partners with Puma Biotech to distribute Nerlynx

    GLOBENEWSWIRE

    ADMA Biologics to Report Q1 2025 Financial Results on May 7

    GLOBENEWSWIRE

    Avalo Therapeutics at Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Larimar Therapeutics Reports First Quarter 2025 Financial Results

    GLOBENEWSWIRE

    I-Mab: Givastomig Abstract Accepted for ESMO GI 2025

    GLOBENEWSWIRE

    BriaCell Reports Positive Phase 3 Data at AACR 2025

    GLOBENEWSWIRE

    Gain Therapeutics to Present Poster at IAPRD 2025 Congress

    GLOBENEWSWIRE

    BioAtla to Participate in the Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Valitor to Present Drug Candidate for Wet AMD at Eye Conferences

    GLOBENEWSWIRE

    Altamira Therapeutics Reports Full Year 2024 Financial Results

    GLOBENEWSWIRE

    Cidara Participate at Citizens Life Sciences Conference

    GLOBENEWSWIRE

    Vaxart Completes Ph 1 Trial Enrollment for Norovirus Pill vaccine

    GLOBENEWSWIRE

    Rakovina Therapeutics Announces 2024 Financial Results & Update

    GLOBENEWSWIRE

    PharmAla Issues Q2 Financial Statements

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.